Healthcare provider profile · identity verified

Shane D Kirkegaard, DO

Internal Medicine · MAPLEWOOD, MN · NPI 1699270744

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	385	85
Levothyroxine Sodium	Levothyroxine Sodium	240	37
Lisinopril	Lisinopril	202	44
Omeprazole	Omeprazole	190	46
Amlodipine Besylate	Amlodipine Besylate	189	40
Gabapentin	Gabapentin	180	41
Losartan Potassium	Losartan Potassium	175	47
Furosemide	Furosemide	149	35
Metoprolol Succinate	Metoprolol Succinate	148	35
Trazodone Hcl	Trazodone Hcl	129	26
Eliquis	Apixaban	119	17
Pantoprazole Sodium	Pantoprazole Sodium	102	23
Carvedilol	Carvedilol	100	24
Ozempic	Semaglutide	99	14
Sertraline Hcl	Sertraline Hcl	92	16
Bumetanide	Bumetanide	88	18
Clopidogrel	Clopidogrel Bisulfate	88	19
Metformin Hcl	Metformin Hcl	82	17
Jardiance	Empagliflozin	81	17
Famotidine	Famotidine	78	17
Diclofenac Sodium	Diclofenac Sodium	74	14
Montelukast Sodium	Montelukast Sodium	74	17
Hydrochlorothiazide	Hydrochlorothiazide	73	20
Tamsulosin Hcl	Tamsulosin Hcl	72	24
Duloxetine Hcl	Duloxetine Hcl	71	12
Prednisone	Prednisone	68	42
Mirtazapine	Mirtazapine	61	12
Potassium Chloride	Potassium Chloride	59	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	12
Simvastatin	Simvastatin	56	12
Tramadol Hcl	Tramadol Hcl	56	19
Warfarin Sodium	Warfarin Sodium	56	suppressed
Metformin Hcl Er	Metformin Hcl	53	13
Oxybutynin Chloride Er	Oxybutynin Chloride	51	suppressed
Tizanidine Hcl	Tizanidine Hcl	51	16
Alendronate Sodium	Alendronate Sodium	50	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	48	19
Carbidopa-Levodopa	Carbidopa/Levodopa	47	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	46	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	22
Ropinirole Hcl	Ropinirole Hcl	44	suppressed
Benazepril Hcl	Benazepril Hcl	43	suppressed
Azithromycin	Azithromycin	42	41
Buspirone Hcl	Buspirone Hcl	38	suppressed
Cephalexin	Cephalexin	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	11
Ondansetron Hcl	Ondansetron Hcl	38	14
Albuterol Sulfate Hfa	Albuterol Sulfate	36	19
Allopurinol	Allopurinol	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	15
Oxycodone Hcl	Oxycodone Hcl	36	13
Cefdinir	Cefdinir	35	34
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Methenamine Hippurate	Methenamine Hippurate	34	suppressed
Celecoxib	Celecoxib	32	suppressed
Myrbetriq	Mirabegron	32	suppressed
Risperidone	Risperidone	32	suppressed
Nystatin	Nystatin	29	14
Ezetimibe	Ezetimibe	28	suppressed
Topiramate	Topiramate	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Donepezil Hcl	Donepezil Hcl	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	25
Glipizide Er	Glipizide	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Spironolactone	Spironolactone	24	11
Glipizide	Glipizide	23	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	23	suppressed
Atenolol	Atenolol	22	suppressed
Ondansetron Odt	Ondansetron	22	12
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	14
Farxiga	Dapagliflozin Propanediol	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Prazosin Hcl	Prazosin Hcl	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Finasteride	Finasteride	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Solifenacin Succinate	Solifenacin Succinate	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Diazepam	Diazepam	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Fluconazole	Fluconazole	15	11
Levetiracetam	Levetiracetam	15	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Lactulose	Lactulose	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Methylprednisolone	Methylprednisolone	12	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error